Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855630 · ClinicalTrials.gov registry record · NA
Combating Alzheimer's Through Sleep and Exercise
A NA study of Alzheimer Disease and Dementia, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04855630 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04855630, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see how sleep and exercise affects dementia risk over time.
Conditions Studied
Interventions
- DEVICE DREEM 2 Headband
- OTHER Exercise Routine
Study Locations (1)
Florida
- University of Miami Hospitals - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04855630
The ClinicalTrials.gov registry entry for NCT04855630 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which DREEM 2 Headband is the first listed.
NCT04855630 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04855630 about?
NCT04855630 is a clinical study titled "Combating Alzheimer's Through Sleep and Exercise". The purpose of this research is to see how sleep and exercise affects dementia risk over time.
What is the current status of trial NCT04855630?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-01. Estimated completion is 2026-03-01.
What conditions does trial NCT04855630 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT04855630?
The interventions under investigation include: DREEM 2 Headband (DEVICE), Exercise Routine (OTHER).
Who is sponsoring clinical trial NCT04855630?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04855630 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.